VIRX - Viracta Therapeutics to Present at Upcoming Investor Conferences in September
PR Newswire
SAN DIEGO , Sept. 7, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (NASDAQ: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that company management will present and be available for virtual one-on-one meetings at the H.C. Wainwright 23 rd Annual Global Investment Conference, September 13 – 15, 2021, the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, September 20 – 23, 2021, and the 2021 Cantor Virtual Global Healthcare Conference, September 27 – 30, 2021.
Details on the presentations can be found below.
H.C. Wainwright 23rd Annual Global Investment Conference |
Presentation Date: |
Corporate presentation will be available on-demand to conference |
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit |
Presentation Date: |
September 21, 2021 |
Presentation Time: |
4:35 PM ET |
Format: |
Corporate presentation |
Webcast Link: |
2021 Cantor Virtual Global Healthcare Conference |
Presentation Date: |
September 30, 2021 |
Presentation Time: |
8:40 AM ET |
Format: |
Corporate presentation |
A replay of the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit presentation will be available on the "Events and Webcasts" section of the Viracta website at https://viracta.investorroom.com/events-and-webcasts .
About Viracta Therapeutics, Inc.
Viracta is a precision oncology company targeting virus-associated malignancies. Viracta's proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in two Phase 2 clinical trials for EBV-positive lymphoma. Viracta is also pursuing application of its inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma, and other virus-related cancers.
For additional information please visit www.viracta.com .
Investor Relations Contact: |
Company Contact: |
Joyce Allaire |
Dan Chevallard |
LifeSci Advisors |
Chief Operating Officer and Chief Financial Officer |
(212) 915-2569 |
(858) 771-4193 |
SOURCE Viracta
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by PR Newswire via Quote Media. Read our full disclaimer.